Explaining biosimiliars to patients and support people

You are invited to take part in a study examining how we can explain biosimilars to patients and their companions.

What's involved?

We are exploring how we can explain biosimilar medications to patients and their support person. A biosimilar is an almost identical copy of a biologic medical product, that is manufactured by a different company.

Participation in this study involves attending a 30-40 minute session at either Greenlane Clinical Centre or the University Grafton Campus. Patients will be asked to attend in-person by themselves or with their companion/support person. At the study session participants will be required to complete some questionnaires and watch a brief video explanation on biosimilars. A $20 shopping voucher will be offered to each participating.

Eligibility criteria

We are looking for participants who meet the following criteria:

  • Patients taking a biologic treatment (Humira, Enbrel, Tocilizumab, Infliximab or Rituximab) for a rheumatic condition
  • You must have a support person or companion, e.g., a spouse/partner, adult child, family member or friend
  • Both the patient and support person/companion need to be at least 18 years old and fluent in English 


If you are interested in taking part in this study, please read the appropriate participant information sheet and consent form below, before contacting:

Chiara Gasteiger
PhD Candidate
Email: cgas770@aucklanduni.ac.nz
Mobile: 021 144 8735

This study has been approved by the Health and Disability Ethics Committee (19/CEN/163) and Auckland District Health Board (A+8700).